These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 31626886)
1. Risk of second primary cutaneous and noncutaneous melanoma after cutaneous melanoma diagnosis: A population-based study. Beroukhim K; Pourang A; Eisen DB J Am Acad Dermatol; 2020 Mar; 82(3):683-689. PubMed ID: 31626886 [TBL] [Abstract][Full Text] [Related]
2. Associations between ocular melanoma and other primary cancers: an international population-based study. Scélo G; Boffetta P; Autier P; Hemminki K; Pukkala E; Olsen JH; Weiderpass E; Tracey E; Brewster DH; McBride ML; Kliewer EV; Tonita JM; Pompe-Kirn V; Chia KS; Jonasson JG; Martos C; Giblin M; Brennan P Int J Cancer; 2007 Jan; 120(1):152-9. PubMed ID: 17036322 [TBL] [Abstract][Full Text] [Related]
3. Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival. Herr MM; Schonfeld SJ; Dores GM; Withrow DR; Tucker MA; Curtis RE; Morton LM J Natl Cancer Inst; 2018 Nov; 110(11):1248-1258. PubMed ID: 29659938 [TBL] [Abstract][Full Text] [Related]
4. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study. Spanogle JP; Clarke CA; Aroner S; Swetter SM J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559 [TBL] [Abstract][Full Text] [Related]
5. Distribution of subsequent primary invasive melanomas following a first primary invasive or in situ melanoma Queensland, Australia, 1982-2010. Youlden DR; Youl PH; Soyer HP; Aitken JF; Baade PD JAMA Dermatol; 2014 May; 150(5):526-34. PubMed ID: 25093216 [TBL] [Abstract][Full Text] [Related]
6. Second Primary Malignancies following a Diagnosis of Conjunctival Melanoma. Mahjoub H; Loya A; Ayaz T; Weng CY Curr Eye Res; 2022 Apr; 47(4):634-641. PubMed ID: 34898336 [TBL] [Abstract][Full Text] [Related]
7. The association between malignant melanoma and noncutaneous malignancies. Wu YH; Kim GH; Wagner JD; Hood AF; Chuang TY Int J Dermatol; 2006 May; 45(5):529-34. PubMed ID: 16700785 [TBL] [Abstract][Full Text] [Related]
8. Italian cancer figures, report 2013: Multiple tumours. AIRTUM Working Group Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384 [TBL] [Abstract][Full Text] [Related]
9. Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden. Wassberg C; Thörn M; Yuen J; Ringborg U; Hakulinen T Br J Cancer; 1996 Jan; 73(2):255-9. PubMed ID: 8546916 [TBL] [Abstract][Full Text] [Related]
10. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts. Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541 [TBL] [Abstract][Full Text] [Related]
11. Risk of second primary in situ and invasive melanoma in a Dutch population-based cohort: 1989-2008. van der Leest RJ; Liu L; Coebergh JW; Neumann HA; Mooi WJ; Nijsten T; de Vries E Br J Dermatol; 2012 Dec; 167(6):1321-30. PubMed ID: 22759226 [TBL] [Abstract][Full Text] [Related]
12. Incidence of invasive cancers following cutaneous malignant melanoma. Levi F; La Vecchia C; Randimbison L; Te VC; Erler G Int J Cancer; 1997 Sep; 72(5):776-9. PubMed ID: 9311593 [TBL] [Abstract][Full Text] [Related]
13. Risk and survival of cutaneous melanoma diagnosed subsequent to a previous cancer. Yang GB; Barnholtz-Sloan JS; Chen Y; Bordeaux JS Arch Dermatol; 2011 Dec; 147(12):1395-402. PubMed ID: 22184761 [TBL] [Abstract][Full Text] [Related]
14. Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009. van der Leest RJT; Hollestein LM; Liu L; Nijsten T; de Vries E J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):382-389. PubMed ID: 28898461 [TBL] [Abstract][Full Text] [Related]
15. Risk of second primary cancers, other than melanoma, in an Italian population-based cohort of cutaneous malignant melanoma patients. Crocetti E; Carli P Eur J Cancer Prev; 2004 Feb; 13(1):33-7. PubMed ID: 15075786 [TBL] [Abstract][Full Text] [Related]
16. Risk of second primary malignancies following a diagnosis of cutaneous malignant melanoma or nonmelanoma skin cancer in Alberta, Canada from 1979 to 2009. Jung GW; Dover DC; Salopek TG Br J Dermatol; 2014 Jan; 170(1):136-43. PubMed ID: 24443913 [TBL] [Abstract][Full Text] [Related]
17. The risk of developing a second, different, cancer among 14 560 survivors of malignant cutaneous melanoma: a study by AIRTUM (the Italian Network of Cancer Registries). Crocetti E; Guzzinati S; Paci E; Falcini F; Zanetti R; Vercelli M; Rashid I; De Lisi V; Russo A; Vitarelli S; Ferretti S; Mangone L; Cesaraccio R; Tumino R; Pannozzo F Melanoma Res; 2008 Jun; 18(3):230-4. PubMed ID: 18477899 [TBL] [Abstract][Full Text] [Related]
18. Risk of Next Melanoma in Patients With Familial and Sporadic Melanoma by Number of Previous Melanomas. Chen T; Fallah M; Försti A; Kharazmi E; Sundquist K; Hemminki K JAMA Dermatol; 2015 Jun; 151(6):607-15. PubMed ID: 25671687 [TBL] [Abstract][Full Text] [Related]
19. Risks of second primary malignancy in patients with cutaneous and ocular melanoma in Denmark, 1943-1989. Swerdlow AJ; Storm HH; Sasieni PD Int J Cancer; 1995 Jun; 61(6):773-9. PubMed ID: 7790110 [TBL] [Abstract][Full Text] [Related]
20. An initial melanoma diagnosis may increase the subsequent risk of prostate cancer: Results from the New South Wales Cancer Registry. Cole-Clark D; Nair-Shalliker V; Bang A; Rasiah K; Chalasani V; Smith DP Sci Rep; 2018 May; 8(1):7167. PubMed ID: 29740153 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]